-
ISEH 2025 | Professor Xue Feng: AAV Vector Gene Therapy Driving Innovation in Hemophilia B Treatment in China
The 54th Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH 2025) was held in Kumamoto, Japan, from September 24 to 27. The event brought together leading global experts to discuss cutting-edge advances in basic hematology, immunology, stem cell biology, and cellular and gene therapies. One of the highlights of the meeting was…
-
CSCO Experts’ Voice | Professor Jianming Guo: Outlook on the Development of China’s Prostate Cancer MDT Model and the Future of AI Applications
Building a Functional MDT for Prostate Cancer Care Q: Prostate cancer MDT involves urology, medical oncology, radiation oncology, pathology, and other specialties. How do you ensure efficient collaboration and avoid…
-
CSCO Experts’ Voice | Professor Xinan Sheng on China-Tailored RCC Guidelines and Innovative Therapies
01 Oncology Frontier – Urology Frontier: As a standing member and secretary-general of the CSCO RCC Expert Committee, you have helped draft and update multiple guideline editions. Could you share…
-
Professor Juan Li: Evaluation and Management Strategies for Kidney Injury During Targeted Plus Immunotherapy in Advanced Renal Cell Carcinoma
Clinical Manifestations and Incidence of Kidney Injury Oncology Frontier: T+I therapy has become the standard for advanced RCC, but kidney injury remains a critical issue. Based on your clinical experience…
Connecting Medical Expertise through Media